news New biomarker identified for early diagnosis of lung cancer 14 May 2018 | By Drug Target Review High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer.
news CKAP4 biomarker identifies stage I lung cancer 10 May 2018 | By Drug Target Review Scientists in Japan have discovered a promising new biomarker – cytoskeleton-associated protein 4 (CKAP4) – for lung cancer, potentially transforming the way the disease is diagnosed and treated.